A better way for a cancer cell to die

Article Abstract:

A study of the lethal effects of chemotherapy on cancer cells shows that, after the fatal blow, cancer cells take different routes to destruction, depending on the chemotherapeutic agent used. The experiments indicate that if a chemotherapeutic agent kills cancer cells in a way that renders them immunogenic, it has a therapeutic benefit over and above the cytotoxic action of the drug.

Cancer cells, Disease/Disorder overview

---

Rational design of cancer-drug combinations

Article Abstract:

The possibility of a new preclinical approach that could hasten the rational design of active and minimally toxic combinations of small-molecule cancer drugs is discussed.

Drug therapy, Combination, Combination drug therapy, Drug overview

---

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

Article Abstract:

A research proved that overall survival improved with Temsirolimus than with Interferon Alfa in patients suffering from advanced renal-cell carcinoma.

Drug therapy, Interferon alpha, Carcinoma, Renal cell, Renal cell carcinoma, Clinical report

Similar abstracts:

• Abstracts: Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer
• Abstracts: Chemotherapy and the war on cancer. A call to arms. The enemy within
• Abstracts: Using post-take ward rounds to facilitate simple discharge. Pre-op scheme reduces patient stays. Moving policy from board to ward
• Abstracts: A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.